±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 673  |  »Ø¸´: 3

worker2013

½ð³æ (ÕýʽдÊÖ)

°®Ñ§Ï°µÄСѧÉú

[½»Á÷] Drug Delivery Nanoparticles Formulation and Characterization ÒÑÓÐ2È˲ÎÓë

Drug_Delivery_Nanoparticles_Formulation_and_Characterization_Drugs_and_the_Pharmaceutical_Sciences
Yashwant_Pathak,_Deepak_Thassu

Drug delivery research is clearly moving from themicro- to the nanosize scale. Nan-otechnology is therefore emerging as a field in medicine that is expected to elicit
significant therapeutic benefits. The development of effective nanodelivery systems
capable of carrying a drug specifically and safely to a desired site of action is one
of the most challenging tasks of pharmaceutical formulation investigators. They
are attempting to reformulate and add new indications to the existing blockbuster
drugs to maintain positive scientific outcomes and therapeutic breakthroughs. The
nanodelivery systems mainly include nanoemulsions, lipid or polymeric nanopar-ticles, and liposomes. Nanoemulsions are primarily used as vehicles of lipophilic
drugs following intravenous administration. On the other hand, the ultimate objec-tive of the other nanodelivery systems is to alter the normal biofate of potent
drug molecules in the body following their intravenous administration to markedly
improve their efficacy and reduce their potential intrinsic severe adverse effects.Drug Delivery Nanoparticles Formulation and Characterization
2.jpg
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

It¡®snowornever.
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

0.8

¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2Â¥2016-04-15 03:35:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
3Â¥2016-04-17 13:52:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hudaiqiang

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

ºÃ¶«Î÷ лл·ÖÏí
»¯Ñ§ÖÆÒ©µÄÓÕ»ó
4Â¥2016-04-18 16:01:18
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ worker2013 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 265Çóµ÷¼Á +9 ÁºÁºÐ£Ð£ 2026-04-01 9/450 2026-04-03 01:25 by С±ý¸Éѧ½ã0
[¿¼ÑÐ] 283·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +19 ÂÞKAKA 2026-04-02 19/950 2026-04-02 23:01 by Âí¶ù¿ì¿ìµØÅÜ
[¿¼ÑÐ] ²ÄÁÏ0856 Ó¢Ò»Êý¶þ 323 Çóµ÷¼Á +10 Ô¬sy 2026-04-01 10/500 2026-04-02 19:52 by xingsh
[¿¼ÑÐ] Çóµ÷¼Á +7 Aniyaio 2026-04-02 7/350 2026-04-02 16:42 by zzsw+
[¿¼ÑÐ] 285Çóµ÷¼Á +14 AZMK 2026-04-02 14/700 2026-04-02 15:54 by ÉϾÅÌìÀ¿Ô£¨ºÃÔ
[¿¼ÑÐ] ³õÊÔ301£¬´úÂë085701»·¾³¹¤³Ì£¬±¾Ë¶Ò»Ö£¬ËÄÁù¼¶Òѹý£¬ÓжþÇøÒ»×÷£¬¹²·¢±í5ƪÂÛÎÄ +6 axibli 2026-04-01 6/300 2026-04-02 13:42 by Ecowxq666£¡
[¿¼ÑÐ] Çóµ÷¼ÁÍÆ¼ö +3 ÄÏɽÄÏ@ 2026-04-01 3/150 2026-04-02 12:09 by xiaoranmu
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©Àí¹¤´óѧ±¾¿Æ211²ÄÁϹ¤³Ì294Çóµ÷¼Á +8 mikasaµÄΧ½í 2026-03-28 9/450 2026-04-02 12:09 by ms629
[¿¼ÑÐ] 279Çóµ÷¼Á +6 ѧ¶øË¼ÙâÖª 2026-04-01 6/300 2026-04-02 09:16 by vgtyfty
[¿¼ÑÐ] 11408 321·ÖÇóµ÷¼Á +3 huchun12138 2026-03-30 4/200 2026-04-01 22:48 by guanxin1001
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤£¨0856£©304ÇóBÇøµ÷¼Á +8 Çñgl 2026-03-30 16/800 2026-04-01 17:58 by Çñgl
[¿¼ÑÐ] 335Çóµ÷¼Á +3 321* 2026-03-31 4/200 2026-04-01 00:00 by 321*
[¿¼ÑÐ] 254²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +3 º²¶¬ÁÖéª 2026-03-30 4/200 2026-03-31 17:53 by yishunmin
[¿¼ÑÐ] 080500-315·Ö¸´ÊÔµ÷¼Á +9 Éϰ¶3821 2026-03-31 9/450 2026-03-31 17:29 by ÌÆãå¶ù
[¿¼ÑÐ] 282Çóµ÷¼Á ²»Ìôרҵ ÇóÊÕÁô +4 Yam. 2026-03-30 5/250 2026-03-31 14:41 by ÍõÁÁ_´óÁ¬Ò½¿Æ´ó
[¿¼ÑÐ] 334Çóµ÷¼Á +7 Trying] 2026-03-31 7/350 2026-03-31 12:33 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 085600£¬×¨Òµ¿Î»¯¹¤Ô­Àí£¬320·ÖÇóµ÷¼Á +6 ´ó²öС×Ó 2026-03-29 6/300 2026-03-31 10:03 by ÂÈ»¯ÑÇÏõõ£
[¿¼ÑÐ] 323·Ö ʳƷÓëÓªÑøµ÷¼Á +3 ºÙooo 2026-03-31 3/150 2026-03-31 09:38 by longlotian
[¿¼ÑÐ] 11408×Ü·Ö309£¬Ò»Ö¾Ô¸¶«ÄÏ´óѧÇóµ÷¼Á£¬²»Ìôרҵ +5 Ì츳´øµ½THU 2026-03-29 6/300 2026-03-30 20:49 by dick_runner
[¿¼ÑÐ] 085405 ¿¼µÄ11408Çó¸÷λÀÏʦ´ø×ß +3 Qiuѧing 2026-03-28 3/150 2026-03-28 09:19 by ÀֺǺǵÄ×·ÃÎÈË
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û